Les Kondejewski
Director/Miembro de la Junta en Ontario Genomics Institute (Private Equity) .
Perfil
Dr. Les Kondejewski is a Director of Research Programs at Ontario Genomics Institute (Private Equity) since April 2013.
Dr. Kondejewski has an extensive background in research and project management, particularly in personalized medicine.
Previously, he held research and program management responsibilities at Caprion Proteomics.
Later, at Diaceutics Inc., he worked with client teams to facilitate the creation of integrated development and commercialization plans for targeted therapies.
Dr. Kondejewski received his BSc from Carleton University and his PhD in biochemistry from Dalhousie University.
Les carried out postdoctoral research and a research fellowship at the Protein Engineering Network of Centres of Excellence at the University of Alberta.
Cargos activos de Les Kondejewski
| Empresas | Cargo | Inicio |
|---|---|---|
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Director/Miembro de la Junta | 01/04/2013 |
Antiguos cargos conocidos de Les Kondejewski.
| Empresas | Cargo | Fin |
|---|---|---|
| DIACEUTICS PLC | Inversor de Capital Privado | 02/12/2012 |
Caprion Proteomics, Inc.
 Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | 02/01/2010 |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Formación de Les Kondejewski.
| Carleton University | Undergraduate Degree |
| Dalhousie University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DIACEUTICS PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Les Kondejewski
